1-4 of 4
Mark S. Carey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1689: Targeting PARP to enhance sensitivity to MEK inhibitors in low-grade serous ovarian cancer

Free
Gamze Bildik, Rumeysa Ozyurt, Weiqun Mao, Marta Llaurado-Fernandez, Hannah Kim, Olivier De Wever, Kwong K. Wong, Mark S. Carey, Robert C. Bast, Zhen Lu
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 1689.
https://doi.org/10.1158/1538-7445.AM2025-1689
Published: 21 April 2025
View articletitled, Abstract 1689: Targeting PARP to enhance sensitivity to MEK inhibitors in low-grade serous ovarian cancer
Journal Articles

Abstract 3476: Mechanistic evaluation of VS-6766 (dual RAF/MEK inhibitor) and defactinib (FAK inhibitor) in low-grade serous ovarian cancer models with correlations to clinical response

Free
Adam R. Stewart, Lisa Pickard, Ekta Paranjape, Victoria Sanchez Perez, Sanjib Chowdhury, Stephanie Lustgarten, Silvia Coma, Jonathan A. Pachter, Mark S. Carey, Gabriel DiMattia, Hannah C. Badham, Toby Prout, Mona Parmar, Muneeb Mahmud, Christina Yap, Matthew G. Krebs, Susana Banerjee, Udai Banerji
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3476.
https://doi.org/10.1158/1538-7445.AM2022-3476
Published: 15 June 2022
View articletitled, Abstract 3476: Mechanistic evaluation of VS-6766 (dual RAF/MEK inhibitor) and defactinib (FAK inhibitor) in low-grade serous ovarian cancer models with correlations to clinical response
Journal Articles

Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability

Available to Purchase
Raunak Shrestha, Marta Llaurado Fernandez, Amy Dawson, Joshua Hoenisch, Stanislav Volik, Yen-Yi Lin, Shawn Anderson, Hannah Kim, Anne M. Haegert, Shane Colborne, Nelson K.Y. Wong, Brian McConeghy, Robert H. Bell, Sonal Brahmbhatt, Cheng-Han Lee, Gabriel E. DiMattia, Stephane Le Bihan, Gregg B. Morin, Colin C. Collins, Mark S. Carey
Journal: Cancer Research
Cancer Res (2021) 81 (7): 1681–1694.
https://doi.org/10.1158/0008-5472.CAN-20-2222
Published: 01 April 2021
View articletitled, Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability
Open the PDF for Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability in another window
Includes: Supplementary data
Journal Articles

Abstract 3116: Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in ovarian cancer

Free
Kirsten M. Timms, Victor Abkevich, Bryan T. Hennessy, Jennifer Potter, Mark S. Carey, Larissa A. Meyer, Russell Broaddus, Karen H. Lu, Srikanth Jammulapati, Lisa FitzGerald, Thomas C. Krivak, Julie A. DeLoia, Alexander Gutin, Gordon B. Mills, Jerry Lanchbury
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3116.
https://doi.org/10.1158/1538-7445.AM2012-3116
Published: 15 April 2012
View articletitled, Abstract 3116: Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in ovarian cancer